English
新闻公告
More
化学进展 2008, Vol. 20 Issue (12): 1998-2011 前一篇   后一篇

• 综述与评论 •

肝素在生长因子控制释放中的应用*

丁珊珊1 崔元璐1 宫政2 尹玉姬2** 姚康德2

  

  1. (1. 天津中医药大学中医药研究院 现代中药发现与制剂技术教育部工程研究中心 天津 300193;2. 天津大学材料科学与工程学院 天津 300072)

  • 收稿日期:2007-12-03 修回日期:2008-01-14 出版日期:2008-12-24 发布日期:2008-12-25
  • 通讯作者: 尹玉姬

Heparin for Growth Factor Delivery systems

Ding Shanshan1 Cui Yuanlu1 Gong Zheng2 Yin Yuji2** Yao Kangde2

  

  1. (1. Research Center of Traditional Chinese Medicine, Engineering Research Center of Modern Chinese Medicine Discovery and Preparation Technique- Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China; 2. School of Materials Science and Engineering, Tianjin University, Tianjin 300072, China)

  • Received:2007-12-03 Revised:2008-01-14 Online:2008-12-24 Published:2008-12-25
  • Contact: Yin Yuji
典型的抗凝血药物肝素作为硫酸化的多糖在体内具有多重生物活性,而这些生物活性是通过与生长因子和细胞因子等蛋白质的相互作用来发挥的。由于它与肝素亲和性生长因子具有特异的糖胺聚糖-蛋白质相互作用,近年来被广泛地应用于生长因子的控制释放中,以达到稳定负载于载体材料特别是水凝胶载体中的生长因子并保持其生物活性、延缓释放的作用。本文介绍了近年来肝素在组织工程用生长因子控制释放系统中应用研究的最新进展。
Heparin, a sulfated polysaccharide and a representative antithrombotic drug, has special binding affinity with a number of biologically important proteins such as growth factors and cytokines, and thereby plays an essential role in the regulation of various biological signaling. Heparin-containing matrices or delivery systems immobilized and protected high-affinity heparin-binding growth factors from degradation, release growth factor in a sustained manner, increased both the stability and activity of the growth factor. In this review, we summarized recently developed hydrogel matrices and scaffolds which contained heparin for growth factor delivery in tissue engineering.

中图分类号: 

()

[1 ] 柏金根(Bo J G) , 杨健(Yang J ) , 朱敦皖(Zhu D W) , 李俊杰(Li J J ) , 姚康德(Yao K D) . 科学通报(Chinese Science Bulletin) , 2006 , 51 : 506 —513
[2 ] Andreas H Z, Matthias P L , Jeffrey A H. Cardiovasc. Pathol . ,2003 , 12 : 295 —310
[3 ] 斯泰因比歇尔A ( Steinbuchel A) . 陈代杰, 罗敏玉翻译(translated by Chen D J and Luo M Y) . 生物高分子(Biopolymers) . 北京: 化学工业出版社(Beijing : Chemical Industry Press) , 2002. 522 —529
[4 ] Rahul R , Sasisekharan V , Sasisekharan R. Chem. Biol . , 2005 ,12 : 267 —277
[5 ] Conrad H E. Heparin-binding Proteins , San Diego : Academic Press , 1998. 15 —20
[6 ] 肖晖( Xiao Hui ) . 国外医学: 免疫学分册( Section of Immunology Foreign Medical Sciences) , 2005 , 28 : 156 —159
[7 ] Christian N , Seeberger P H. Chem. Biol . , 2005 , 12 : 731 —756
[8 ] Ishan C , Linhardt R J . Angew. Chem. Int . Ed. , 2002 , 41 :390 —412
[9 ] Raman R , Venkataraman G, Ernst S , et al . PNAS , 2003 , 100 :2357 —2362
[10] Stauber D J , DiGabriele A D , Hendrickson W A. PNAS , 2000 ,97 : 49 —54
[11] Taguchi T, Kishida A , Sakamoto N , et al . J . Biomed. Mater.Res. , 1998 , 41 : 386 —391
[12] Mairea M, Logeart-Avramogloub D , Degatb M C , et al .Biomaterials , 2005 , 26 : 1771 —1780
[13] Ferrara N. Kidney Int . , 1999 , 56 : 794 —814
[14] Ashikari-Hada S , Habuchi H , Kariya Y, et al . J . Biol . Chem. ,2005 , 280 : 31508 —31515
[15] Rubin J S , Day R M, Breckenridge D , et al . J . Biol . Chem. ,2001 , 276 : 32977 —32983
[16] Tessmar J K, Gopferich A M. Adv. Drug Delivery Rev. , 2007 ,59 : 274 —291
[17] Lee K Y, Yuk S H. Prog. Polym. Sci . , 2007 , 32 : 669 —697
[18] Pieper J S , Hafmans T, Van Wachem P B , et al . J . Biomed.Mater. Res. , 2002 , 62 : 185 —194
[19] Wissink M J B , Beernink R , Pieper J S , Feijen J , et al .Biomaterials , 2001 , 22 : 2291 —2299
[20] Jeon O , Ryu S H , Chung J H , et al . J . Control . Rel . , 2005 ,105 : 249 —259
[21] Jeon O , Kang S W, Lim H W, et al . Biomaterials , 2006 , 27 :1598 —1607
[22] Sakiyama-Elbert S E , Hubbell J A. J . Control . Rel . , 2000 , 65 :389 —402
[23] Cai S S , Liu YC , Shu X Z, Prestwich G D. Biomaterials , 2005 ,26 : 6054 —6067
[24] Pike D B , Cai S S , Pomraning K R , Prestwich G D , et al .Biomaterials , 2006 , 27 : 5242 —5251
[25] Liu Y C , Cai S S , Shu X Z, et al . Wound Rep. Reg. , 2007 ,15 : 245 —251
[26] Liu L S , Ng C K, Thompson A Y, et al . J . Biomed. Mater.Res. , 2002 , 62 : 128 —135
[27] Ishihara M, Ono K, Ishikawa K, et al . J . Biochem. , 2000 ,127 : 797 —803
[28] Ishihara M, Sato Y, Yura H , et al . J . Biomed. Mater. Res. ,2000 , 50 : 144 —152
[29] Ishihara M, Sato M, Hattori H , et al . J . Biomed. Mater. Res. ,2001 , 56 : 536 —544
[30] Sato M, Ishihara M, Ishihara M,et al . J . Biomed. Mater. Res.2007 , 83B : 181 —188
[31] Ishihara M, Obara K, Ishizuka T, et al . J . Biomed. Mater.Res. , 2003 , 64A: 551 —559
[32] Ishihara M, Obara K, Nakamura S , et al . J . Artif . Organs ,2006 , 9 : 8 —16
[33] Obara K, Ishihara M, Fujita M, et al . Wound Rep. Reg. ,2005 , 13 :390 —397
[34] Fujita M, Ishihara M, Simizu M, et al . Biomaterials , 2004 ,2004 : 699 —706
[35] Fujita M, Ishihara M, Shimizu M, et al . Wound Rep. Reg. ,2007 , 15 : 58 —65
[36] Nakamura S , Ishihara M, Obara K, et al . J . Biomed. Mater.Res. , 2006 , 78A: 364 —371
[37] Tanihara M, Suzuki Y, Yamamoto E , et al . J . Biomed. Mater.Res. , 2001 , 56 :216 —221
[38] Ohta M, Suzuki Y, Chou H , et al . J . Biomed. Mater. Res. ,2004 , 71A: 661 —668
[39] Chinen N , Tanihara M, Nakagawa M, et al . J . Biomed. Mater.Res. , 2003 , 67A: 61 —68
[40] Andreopoulosa F M, Persauda I. Biomaterials , 2006 , 27 : 2468 —2476
[41] Lee J S , Go D H , Bae J W, et al . J . Control . Rel . , 2007 , 117 :204 —209
[42] Chung Y I , Lee S Y, Tae G. Coll Surfaces A: Physicochem.Eng. Aspects , 2006 , 284P285 : 480 —484
[43] Yoon J J , Chung H J , Park T G. J . Biomed. Mater. Res. ,2007 , 83A: 597 —605
[44] Benoit D S W, Anseth K S. Acta Biomaterialia , 2005 , 1 : 461 —470
[45] Cushing M C , Liao J T, Jaeggli M P , et al . Biomaterials , 2007 ,28 ; 3378 —3387
[46] Yamaguchi N. , Kiick K L. Biomacromolecules , 2005 , 6 :1921 —1930
[47] Nie T, Baldwin A , Yamaguchi N , et al . J . Control . Rel . ,2007 , 122 : 287 —296
[48] Yoon J J , Chung H J , Lee H J , et al . J . Biomed. Mater. Res. ,2006 , 79A: 934 —942
[49] Chung H J , Kim H K, Yoon J J , et al . Pharmac. Res. , 2006 ,23 : 1835 —1841
[50] Yao C , Roderfeld M, Rath T, et al . Biomaterials , 2006 , 27 :1608 —1616
[51] Riley C M, Fuegy P W, Firpob M A , et al . Biomaterials , 2006 ,27 : 5935 —5943
[52] Lee K W, Yoon J J , Lee J H , et al . Transpl . Proc. , 2004 , 36 :2464 —2465
[53] Tae G, Scatena M, Stayton P S , et al . J . Biomater. Sci . Polym.Ed. , 2006 , 17 : 187 —197
[54] Schroeder-Tefft J A , Bentz H , Estridge T D. J . Control . Rel . ,1997 , 49 : 291 —298
[55] Sakiyama-Elbert S E , Hubbell J A. J . Control . Rel . , 2000 , 69 :149 —158
[56] Liao I C , Wan A C A , Yim E K F , et al . J . Control . Rel . ,2005 , 104 : 347 —358
[57] Seo S J , Choi Y J , Akaike T, et al . Tissue Eng. , 2006 , 12 :33 —44

[1] 陈一明, 李慧颖, 倪鹏, 方燕, 刘海清, 翁云翔. 含儿茶酚基团的湿态组织粘附水凝胶[J]. 化学进展, 2023, 35(4): 560-576.
[2] 李良春, 郑仁林, 黄毅, 孙荣琴. 多组分自组装小分子水凝胶中的自分类组装[J]. 化学进展, 2023, 35(2): 274-286.
[3] 宫悦, 程一竹, 胡银春. 高分子导电水凝胶的制备及在柔性可穿戴电子设备中的应用[J]. 化学进展, 2022, 34(3): 616-629.
[4] 钟琴, 周帅, 王翔美, 仲维, 丁晨迪, 傅佳骏. 介孔二氧化硅基智能递送体系的构建及其在各类疾病治疗中的应用[J]. 化学进展, 2022, 34(3): 696-716.
[5] 李红, 史晓丹, 李洁龄. 肽自组装水凝胶的制备及在生物医学中的应用[J]. 化学进展, 2022, 34(3): 568-579.
[6] 宋路杰, 吴友平, 邓建平. 手性药物的对映体选择性释放[J]. 化学进展, 2021, 33(9): 1550-1559.
[7] 李立清, 吴盼旺, 马杰. 双网络凝胶吸附剂的构建及其去除水中污染物的应用[J]. 化学进展, 2021, 33(6): 1010-1025.
[8] 杨宇州, 李政, 黄艳凤, 巩继贤, 乔长晟, 张健飞. MOF基水凝胶材料的制备及其应用[J]. 化学进展, 2021, 33(5): 726-739.
[9] 李超, 乔瑶雨, 李禹红, 闻静, 何乃普, 黎白钰. MOFs/水凝胶复合材料的制备及其应用研究[J]. 化学进展, 2021, 33(11): 1964-1971.
[10] 张开宇, 高国伟, 李延生, 宋钰, 温永强, 张学记. DNA水凝胶在生物传感中的应用和发展[J]. 化学进展, 2021, 33(10): 1887-1899.
[11] 吴晓晓, 马开庆. 百部生物碱的全合成[J]. 化学进展, 2020, 32(6): 752-760.
[12] 张继东, 刘阿晨, 陈娇, 袁光辉, 金华峰. 基于生物素的荧光有机小分子及其应用[J]. 化学进展, 2020, 32(5): 594-603.
[13] 宁鹏, 程云辉, 许宙, 丁利, 陈茂龙. 金属-有机框架材料在活性肽富集中的应用[J]. 化学进展, 2020, 32(4): 497-504.
[14] 于秋灵, 李政, 窦春妍, 赵义平, 巩继贤, 张健飞. pH敏感性智能水凝胶的设计及其应用[J]. 化学进展, 2020, 32(2/3): 179-189.
[15] 苏喜, 葛闯, 陈李, 徐溢. 基于水凝胶的细菌传感检测[J]. 化学进展, 2020, 32(12): 1908-1916.